Moreover, in vitro studies have shown that the combination of CDs with the inhibitors of signaling pathways significantly increases the anti-tumor efficacy of the therapy by reducing the migration and invasion of tumor cells and lowering the levels of proteins responsible for cell survival and proliferation, such as Akt, Bcl-2, STAT3, and Slug [68]. The gene discussed is AKT1; the disease is neoplasm.